DOI QR코드

DOI QR Code

Use of Tandem Mass Spectrometry for Newborn Screening of 6 Lysosomal Storage Disorders in a Korean Population

  • Han, Min-Je (Department of Laboratory Medicine, Seoul National University Bundang Hospital) ;
  • Jun, Sun-Hee (Department of Laboratory Medicine, Seoul National University Bundang Hospital) ;
  • Song, Sang-Hoon (Department of Laboratory Medicine, Seoul National University Bundang Hospital) ;
  • Park, Kyoung-Un (Department of Laboratory Medicine, Seoul National University Bundang Hospital) ;
  • Kim, Jin-Q (Department of Laboratory Medicine, Konkuk University) ;
  • Song, Jung-Han (Department of Laboratory Medicine, Seoul National University Bundang Hospital)
  • Published : 2011.10.30

Abstract

Background: We evaluated the performance of multiplex tandem mass spectrometry (MS/MS) in newborn screening for detection of 6 lysosomal storage disorders (LSDs), namely, Niemann-Pick A/B, Krabbe, Gaucher, Fabry, and Pompe diseases and Hurler syndrome. Methods: We revised the conditions and procedures of multiplex enzyme assay for the MS/MS analysis and determined the precision of our enzyme assay and the effects of sample amounts and incubation time on the results. We also measured the degree of correlation between the enzyme activities in the dried blood spots (DBSs) and those in the leukocytes. DBSs of 211 normal newborns and 13 newborns with various LSDs were analyzed using our revised methods. Results: The intra- and inter-assay precisions were 2.9-18.7% and 8.1-18.1%, respectively. The amount of product obtained was proportional to the DBS eluate volume, but a slight flattening was observed in the product vs. sample volume curve at higher sample volumes. For each enzyme assay, the amount of product obtained increased linearly with the incubation period (range, 0-24 hr). Passing and Bablok regression analysis revealed that the enzyme activities in the DBSs and those in the leukocytes were favorably correlated. The enzyme activities measured in the DBSs were consistently lower in patients with LSDs than in normal newborns. Conclusions: The performance of our revised techniques for MS/MS detection and enzyme assays was of the generally acceptable standard. To our knowledge, this is the first report on the use of MS/MS for newborn screening of LSDs in an Asian population.

Keywords

References

  1. Futerman AH and van Meer G. The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol 2004;5:554-65. https://doi.org/10.1038/nrm1423
  2. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lyso-somal storage disorders. JAMA 1999;281:249-54. https://doi.org/10.1001/jama.281.3.249
  3. Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 2003;49:1797-817. https://doi.org/10.1373/clinchem.2003.022178
  4. Lehotay DC, Hall P, Lepage J, Eichhorst JC, Etter ML, Greenberg CR. LC-MS/MS progress in newborn screening. Clin Biochem 2011;44:21-31. https://doi.org/10.1016/j.clinbiochem.2010.08.007
  5. Ko DH, Jun SH, Park HD, Song SH, Park KU, Kim JQ, et al. Multiplex enzyme assay for galactosemia using ultraperformance liquid chromatography-tandem mass spectrometry. Clin Chem 2010; 56:764-71. https://doi.org/10.1373/clinchem.2009.139618
  6. Ko DH, Jun SH, Park KU, Song SH, Kim JQ, Song J. Newborn screening for galactosemia by a second-tier multiplex enzyme assay using UPLC-MS/MS in dried blood spots. J Inherit Metab Dis 2011; 34:409-14. https://doi.org/10.1007/s10545-011-9291-y
  7. Li Y, Scott CR, Chamoles NA, Ghavami A, Pinto BM, Turecek F, et al. Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem 2004;50:1785-96. https://doi.org/10.1373/clinchem.2004.035907
  8. Zhang XK, Elbin CS, Chuang WL, Cooper SK, Marashio CA, Beauregard C, et al. Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry. Clin Chem 2008;54:1725-8. https://doi.org/10.1373/clinchem.2008.104711
  9. Chamoles NA, Blanco M, Gaggioli D. Diagnosis of alpha-L-iduronidase deficiency in dried blood spots on filter paper: the possibility of newborn diagnosis. Clin Chem 2001;47:780-1.
  10. Wang D, Eadala B, Sadilek M, Chamoles NA, Turecek F, Scott CR, et al. Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns. Clin Chem 2005;51:898-900. https://doi.org/10.1373/clinchem.2004.047167
  11. Blanchard S, Sadilek M, Scott CR, Turecek F, Gelb MH.Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I.Clin Chem 2008;54:2067-70. https://doi.org/10.1373/clinchem.2008.115410
  12. Duffey TA, Bellamy G, Elliott S, Fox AC, Glass M, Turecek F, et al. A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler). Clin Chem 2010;56:1854-61. https://doi.org/10.1373/clinchem.2010.152009
  13. Duffey TA, Sadilek M, Scott CR, Turecek F, Gelb MH. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Anal Chem 2010;82:9587-91. https://doi.org/10.1021/ac102090v
  14. Khaliq T, Sadilek M, Scott CR, Turecek F, Gelb MH. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis IVA. Clin Chem 2011;57:128-31. https://doi.org/10.1373/clinchem.2010.149880
  15. Wolfe BJ, Blanchard S, Sadilek M, Scott CR, Turecek F, Gelb MH. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis II (Hunter Syndrome). Anal Chem 2011; 83:1152-6. https://doi.org/10.1021/ac102777s

Cited by

  1. Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry vol.51, pp.1, 2011, https://doi.org/10.1515/cclm-2012-0472
  2. Quantification of psychosine in the serum of twitcher mouse by LC-ESI-tandem-MS analysis vol.80, pp.None, 2011, https://doi.org/10.1016/j.jpba.2013.02.039
  3. LC-MS/MS in the routine clinical laboratory: has its time come? vol.406, pp.9, 2014, https://doi.org/10.1007/s00216-013-7542-5
  4. A column‐switching HPLC‐MS/MS method for mucopolysaccharidosis type I analysis in a multiplex assay for the simultaneous newborn screening of six lysosomal storage disorders vol.28, pp.8, 2011, https://doi.org/10.1002/bmc.3133
  5. Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Measurement of Leukocyte Arylsulfatase A Activity Using a Natural Substrate vol.35, pp.1, 2011, https://doi.org/10.3343/alm.2015.35.1.165
  6. Spectrum Analysis of Common Inherited Metabolic Diseases in Chinese Patients Screened and Diagnosed by Tandem Mass Spectrometry vol.29, pp.2, 2011, https://doi.org/10.1002/jcla.21745
  7. Diagnosis, classification and treatment of mucopolysaccharidosis type I vol.3, pp.3, 2015, https://doi.org/10.1517/21678707.2015.1016908
  8. Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report vol.17, pp.None, 2011, https://doi.org/10.1186/s12881-016-0338-7
  9. Successful newborn screening for Gaucher disease using fluorometric assay in China vol.62, pp.8, 2011, https://doi.org/10.1038/jhg.2017.36
  10. Validation of a Multiplex Tandem Mass Spectrometry Method for the Detection of Selected Lysosomal Storage Diseases in Dried Blood Spots vol.5, pp.None, 2011, https://doi.org/10.1177/2326409817692360
  11. Newborn Screening for Lysosomal Storage Disorders in Belgium : The Importance of Sex- and Age-Dependent Reference Ranges vol.5, pp.None, 2011, https://doi.org/10.1177/2326409817744231
  12. New Born Screening Tests Status of Lysosomal Storage Diseases in Korea vol.3, pp.1, 2017, https://doi.org/10.19125/jmrd.2017.3.1.35